CDEK
← All drugs Report issue

bcma-pd1-cart cell

Cell therapyexperimental

Clinical trial activity

35 trials · 32 clinical orgs · 0 marketing orgs

Phase 1
23
Phase 2
17
Phase 3
1
Phase 4
0

Earliest trial started Aug 6, 2014 (NCT02215967)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • BCMAImmunity, passive

    BCMA immunity, passive

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • anti-bcma car-t cells
  • cart-138/bcma cells
  • cart-bcma

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07200089Phase 1Jan 31, 2026NeoImmuneTech, Inc., Washington University in St. Louis
NCT07089121Phase 1/Phase 2 (Phase 2)Dec 31, 2025Cartesian Therapeutics
NCT07106684Phase 2Aug 10, 2025China Academy of Chinese Medical Sciences
NCT07106710Phase 2Aug 10, 2025China Academy of Chinese Medical Sciences
NCT07106736Phase 2Aug 10, 2025China Academy of Chinese Medical Sciences
NCT07085559Early Phase 1 (Phase 1)Jun 23, 2025Anhui Medical University, Leman Biotech Co., Ltd
NCT06799247Phase 3May 6, 2025Cartesian Therapeutics
NCT07109323Phase 1/Phase 2 (Phase 2)Mar 3, 2025China Academy of Chinese Medical Sciences, Government of China
NCT06983951N/AFeb 20, 2025Beijing Boren Hospital
NCT06681337Early Phase 1 (Phase 1)Nov 25, 2024Nanjing University, Shanghai Bioray Laboratory Inc.
NCT06038474Phase 2Nov 1, 2023Cartesian Therapeutics
NCT05740891Phase 1Mar 31, 2023Yake Biotechnology Ltd., Zhejiang University
NCT05712083Phase 2Jan 30, 2023Yake Biotechnology Ltd., Zhejiang University
NCT05302648Early Phase 1 (Phase 1)Feb 9, 2022Hrain Biotechnology Co., Ltd., Second Military Medical University
NCT04816526Phase 2Oct 31, 2021Cartesian Therapeutics
NCT05150522Phase 1/Phase 2 (Phase 2)Jul 1, 2021Shenzhen University
NCT04447573N/AJun 30, 2020Hebei Senlang Biotechnology Inc., Ltd., Ludaopei Hospital
NCT04626752Early Phase 1 (Phase 1)Apr 1, 2020Hebei Senlang Biotechnology Inc., Ltd., Hebei University
NCT04272151Phase 1/Phase 2 (Phase 2)Dec 1, 2019Chongqing Medical University, Chongqing Precision Biotech Co., Ltd
NCT04146051Phase 1/Phase 2 (Phase 2)Nov 1, 2019Cartesian Therapeutics
Showing 20 of 35 trials
Page 1 / 2

Organizations

Research & Development (32)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cartesian TherapeuticsFor profit6632018
China Academy of Chinese Medical SciencesAcademic/Hospital4412025
People's Liberation Army of ChinaGovernment4222016
Henan Medical UniversityAcademic/Hospital3222017
The Beijing Pregene Science and Technology Company, Ltd.For profit3122017
Chongqing Medical UniversityAcademic/Hospital2012019
Chongqing Precision Biotech Co., LtdFor profit2212019
Hebei Senlang Biotechnology Inc., Ltd.For profit2222020
National Cancer Institute (NCI)Government2212014
Shanghai Bioray Laboratory Inc.For profit2222018
Yake Biotechnology Ltd.Government2022023
Zhejiang UniversityAcademic/Hospital2222023
Anhui Medical UniversityAcademic/Hospital1112025
Beijing Boren HospitalAcademic/Hospital1112025
CARsgen Therapeutics, Ltd.For profit1012017
Central South UniversityAcademic/Hospital1012018
Government of ChinaGovernment1012025
Hebei UniversityAcademic/Hospital1012020
Henan University of Traditional Chinese MedicineAcademic/Hospital1112017
Hrain Biotechnology Co., Ltd.For profit1112022
32 organizations
Page 1 / 2